The wide-ranging discussion with witnesses from Stanford, Johns Hopkins, and Editas Medicine touched on recent advances in research and questions of safety.
In Nature this week: new class of base editors, additional breast cancer risk loci, and more.
The initiative's four research projects will use use genetic and other technologies to detect and treat cancer at its earliest stages.
Johns Hopkins' Evgeny Izumchenko is also developing a blood test for the non-invasive detection and followup of early tumors.
A Johns Hopkins team reported its finding in JAMA Cardiology, backed by SNP array data from 21,870 participants culled from several large cardiovascular studies.
A new set of papers reveals a range of gene expression influencers, identified using thousands of samples collected for the Genotype-Tissue Expression project.
In PNAS this week: links between the gut microbiome and multiple sclerosis, and more.
Hopkins' Joshua Sharfstein writes at JAMA Forum about how the Trump administration has been dealing with scientific evidence.
Johns Hopkins researchers added protein analysis to circulating tumor DNA testing to better detect early-stage pancreatic cancer.
Investigators retraced features contributing to Lyme disease spread by sequencing 146 Borrelia burgdorferi isolates collected in North America since the 1980s.
A UK woman is suing three National Health Service Trusts for not telling her about her father's Huntington's disease diagnosis, the BBC reports.
LiveScience reports that a novel mutation in the LPL gene was uncovered in three siblings with very high triglyceride levels.
The president of Nankai University is embroiled in a data manipulation scandal, the South China Morning Post reports.
In PNAS this week: cytotoxic CD4 T cell signature in supercentenarians, evolutionary history of beetles, and more.